Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Lipocurc by SignPath Pharma for Metastatic Prostate Cancer: Likelihood of Approval
Lipocurc is under clinical development by SignPath Pharma and currently in Phase II for Metastatic Prostate Cancer. According to GlobalData,...